MGP Ingredients (MGPI) experienced a notable increase in revenue, with a 15.5% rise, reaching $180.8 million in Q4 2024, compared to $156.4 million in the same period the previous year1. However, the cost of goods sold also saw a significant uptick, rising by 17.6% to $106.32 million, which could indicate challenges in cost management. On the other hand, research and development (R&D) expenses remained relatively stable, increasing by 3.3% to $30.96 million1. Sales and marketing expenses, as well as general and administrative expenses, saw more modest increases, with overall expenses rising by approximately 10%1. This suggests that while the company is growing, it is also investing in areas such as R&D to maintain its competitive edge.
MGPI Selling, General, and Administrative Expenses, Cost of Goods Sold...